KPV: What the Research Shows About This Anti-Inflammatory Tripeptide

What it is

Alpha-MSH is a hormone with two very different jobs. It tells skin cells to make pigment, which is why its synthetic cousin melanotan II is sold as a tanning peptide. And it dampens inflammation, an effect that lives in the last three amino acids of the molecule: lysine, proline, valine. KPV is those three, made on their own (Brzoska et al., 2008).

Cut away from the rest of the hormone, KPV does not bind the receptor that drives pigment, so it does not tan skin. It keeps the anti-inflammatory effect, and it is small enough to be absorbed in ways most peptides cannot, including, in mice, by mouth.

What it is studied for

Inflammatory bowel disease, mainly, in mouse models of colitis. Skin inflammation in animal models. Antimicrobial activity in the lab. Nothing in humans.

What the evidence actually shows

In animals

The strongest line of work is gut inflammation. In mice with chemically induced colitis, KPV reduced inflammatory markers, limited tissue damage, and improved the animals’ condition, whether it was injected or given by mouth (Kannengiesser et al., 2008). Later work showed the gut absorbs it through a transporter meant for dietary peptides, which explains why oral dosing worked and is unusual for a peptide.

In animal models of skin inflammation, contact dermatitis and allergic reactions, KPV cut inflammatory cell infiltration and cytokine release. The relevance to human eczema or psoriasis has not been tested.

In the lab

Alpha-MSH and its fragments block NF-κB, a master switch inside cells that turns on inflammatory genes. KPV can get inside cells and act on that switch directly, which most peptides cannot (Catania et al., 2003). In a dish it also kills some bacteria and Candida yeast at high concentrations.

In humans

No published trial, no case series, nothing. Everything below the animal tier is user reports.

From user reports

People with irritable bowel or inflammatory bowel symptoms describe fewer flares on oral or injected KPV. People with eczema or acne report calmer skin from topical use. Others report nothing. There is no study behind any of it, and gut symptoms wax and wane on their own.

How it works

Inflammation runs on NF-κB. When a cell senses damage or infection, NF-κB switches on the genes that make inflammatory signals. KPV gets into the cell and interferes with that switch, so fewer signals get made. Because it is a fragment of a hormone the body already uses for this, the mechanism is not exotic; the open question is whether enough of it reaches the right tissue in a person to matter.

How it is used in studies

The mouse colitis work used oral and injected KPV at doses that do not translate cleanly to people. Users report 200 to 500 micrograms a day under the skin, or oral capsules for gut complaints, or a cream for skin, in courses of a few weeks. None of it comes from a human study. See the storage guide.

Side effects and unknowns

Nothing has been documented in people, because nothing has been studied in people. Users report injection-site redness and little else. Because KPV does not activate the pigment receptor, it should not darken skin the way melanotan does, and users do not report that.

The unknowns: whether it does anything in humans; whether dampening NF-κB long term, a switch the immune system needs, has a cost; whether the antimicrobial effect seen in a dish means anything in a gut full of bacteria you want to keep. See the safety guide.

How it compares

• BPC-157: the other gut peptide, studied in rats for healing the gut lining rather than switching off inflammation; also no human trial.
• LL-37: the body’s own antimicrobial peptide, with far stronger antimicrobial data and inflammation effects that cut both ways.
• Thymosin alpha-1: immune regulation with actual clinical use abroad.
• Melanotan II: the full alpha-MSH mimic, with the tanning and the side effects KPV was designed to leave behind.

Legal status

Not approved for any use anywhere. Sold as a research chemical; some compounding pharmacies have offered it, and the FDA has moved to restrict peptides in that category. Not on the WADA Prohibited List.

Bottom line

KPV is a clean idea, the anti-inflammatory part of a natural hormone without the tanning part, with consistent results in mice and nothing in people. If it works in humans, nobody has checked. It is among the more plausible untested peptides, and untested is the word that matters.

References

1. Brzoska T, et al. (2008). Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo. Endocr Rev. PubMed
2. Kannengiesser K, et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. PubMed
3. Catania A, et al. (2003). New insights into the functions of alpha-MSH and related peptides in the immune system. Ann N Y Acad Sci. PubMed

See also

• Peptide
  BPC-157: What the Research Actually Shows About This Healing Peptide

  A plain review of the animal research on BPC-157, what it suggests about healing, and why none of it has been confirmed in people.

• Peptide
  GHK-Cu (Copper Peptide): Research, Mechanism, and Evidence for Tissue Repair

  GHK-Cu is a copper-carrying peptide your body makes naturally, studied mainly as a skin cream for aging skin and, in animals, for wound healing.

• Peptide
  LL-37: What the Research Shows About This Human Antimicrobial Peptide

  LL-37 is the only cathelicidin peptide humans make, a 37-amino-acid molecule that kills bacteria directly and helps close wounds. It is well studied in the lab and in animals, and injecting it has never been tested in a person.